CoChat

Le rétrovirus humain oncogène HTLV-1 : épidémiologie descriptive et moléculaire, origine, évolution et aspects diagnostiques et maladies associées

Gessain, A. · 2011 · Bulletin de la Société de pathologie exotique
Cited by 58

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human retrovirus discovered in 1980. It is estimated that around 10-20 million people are infected with HTLV-1 worldwide. However, HTLV-1 is not a ubiquitous virus. Indeed, HTLV-1 is present throughout the world with clusters of high endemicity including mainly southern Japan, the Caribbean region, parts of South America and intertropical Africa, with foci in the Middle East and Australia. The origin of this puzzling geographical repartition is probably linked to a founder effect in certain human groups. In the high endemic areas, 0.5 to 50% of the people have antibodies against HTLV-1 antigens. HTLV-1 seroprevalence increases with age, especially in women. HTLV-1 has 3 modes of transmission: mother to child, mainly through prolonged breastfeeding (> 6 months); sexual, mainly but not exclusively occurring from male to female; and by blood products contaminated by infected lymphocytes. HTLV-1 is mainly the etiological agent of two very severe diseases: a malignant T CD4+ cell lymphoproliferation of very poor prognosis, named adult T-cell leukemia/lymphoma (ATLL), and a chronic neuro-myelopathy named tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM). HTLV-1 is also associated with rare anterior uveitis, infective dermatitis and myositis in some high HTLV-1 endemic areas. The repartition of the different molecular subtypes or genotypes is mainly linked to the geographical origin of the infected persons but not to the associated pathology. HTLV-1 possesses a remarkable genetic stability probably linked to viral amplification via clonal expansion of infected cells rather than by reverse transcription. This stability can be used as a molecular tool to gain better insights into the origin, evolution and modes of dissemination of HTLV-1 and infected populations. HTLV-1 originated in humans through interspecies transmission from STLV-1, a very closely related retrovirus, highly endemic in several populations of apes and Old World monkeys.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13149-011-0174-4

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 89

  1. Afonso PV, Mekaouche M, Mortreux F, et al (2010) Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood 116(19):3802–3808. Epub 2010 Jun 29 · DOI · Paper page
  2. Araujo A, Hall WW (2004) Human T-lymphotropic virus type II and neurological disease. Ann Neurol 56(1):10–19 · DOI · Paper page
  3. Araujo AQ, Leite AC, Dultra SV, Andrada-Serpa MJ (1995) Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci 129(2):147–151 · DOI
  4. Araujo AQ, Silva MT (2006) The HTLV-1 neurological complex. Lancet Neurol 5(12):1068–1076 · DOI · Paper page
  5. Arisawa K, Soda M, Endo S, et al (2000) Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 85(3):319–324 · DOI · Paper page
  6. Bazarbachi A, Plumelle Y, Carlos-Ramos J, et al (2010) Metaanalysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 28(27):4177–4183. Epub 2010 Jun 28 · DOI · Paper page
  7. Besson C, Gonin C, Brebion A, et al (2001) Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T-cell leukemia/lymphoma. Leukemia 15(5):828–831 · DOI
  8. Besson C, Plumelle Y, Arnulf B, et al (2001) Leucémie/lymphome T de l’adulte. Aspects cliniques. Presse Med 30(5):239–242
  9. Bittencourt AL, Barbosa HS, Vieira MD, Farre L (2009) Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases. Acta Oncol 48(4):598–604 · DOI
  10. Bittencourt AL, de OliveiraMde F (2010) Cutaneous manifestations associated with HTLV-1 infection. Int J Dermatol 49(10):1099–1110 · DOI
  11. Brites C, Sampalo J, Oliveira A (2009) HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev 11(1):8–16
  12. Calattini S, Chevalier SA, Duprez R, et al (2005) Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2:30 · DOI · Paper page
  13. Cassar O, Capuano C, Bassot S, et al (2007) Human T lymphotropic virus type 1 subtype C melanesian genetic variants of the Vanuatu Archipelago and Solomon Islands share a common ancestor. J Infect Dis 196(4):510–521. · DOI · Paper page
  14. Cavrois M, Wain-Hobson S, Gessain A, et al (1996) Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. Blood 88(12): 4646–4650 · DOI
  15. Couroucé AM, Pillonel J, Lemaire JM, et al (1993) Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS 7(6):841–847 · DOI
  16. Daenke S, Nightingale S, Cruickshank JK, Bangham CR (1990) Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol 64(3):1278–1282 · DOI · Paper page
  17. Desdouits M, Cassar O, Maisonobe T, et al (2011) Immunohistochemical and virological features of HTLV-1-associated myosites: a study of 13 patients from West Indies and Africa. Retrovirology 8(Suppl 1):A41 · doi:10.1186/1742-4690-8-s1-a41
  18. Fouchard N, Mahe A, Huerre M, et al (1998) Cutaneous T-cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T-cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases. Leukemia 12(4):578–585 · DOI
  19. Fujino R, Kawato K, Ikeda M, et al (1991) Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res 82(4):367–370 · DOI
  20. Gabet AS, Mortreux F, Talarmin A, et al (2000) High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T-cells in HTLV-1 carriers with strongyloidiasis. Oncogene 19(43):4954–4960 · DOI
  21. Gasmi M, Farouqi B, d’Incan M, Desgranges C (1994) Long terminal repeat sequence analysis of HTLV type I molecular variants identified in four north African patients. AIDS Res Hum Retroviruses 10(10):1313–1315 · DOI
  22. Gérard Y, Lepere JF, Pradinaud R, et al (1995) Clustering and clinical diversity of adult T-cell leukemia/lymphoma associated with HTLV-I in a remote black population of French Guiana. Int J Cancer 60(6):773–776 · DOI
  23. Gessain A, Barin F, Vernant JC, et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2(8452):407–410 · DOI · Paper page
  24. Gessain A, Dezzuti CS, Cowan EP, Lal RB (2007) Human T-cell lymphotropic virus types 1 and 2. In: Murray PR (ed) Manual of clinical microbiology. ASM Press, Washington, DC, pp 1330–1339
  25. Gessain A, Gallo RC, Franchini G (1992) Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol 66(4):2288–2295 · DOI · Paper page
  26. Gessain A, Gout O (1992) Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 117(11):933–946 · DOI · Paper page
  27. Gessain A, Pecon-Slattery J, Meertens L, Mahieux R (2000) Origins of HTLV-1 in South America. Nat Med 6(3):232; author reply 233 · DOI
  28. Gessain A, Saal F, Giron ML, et al (1990) Cell surface phenotype and human T lymphotropic virus type 1 antigen expression in 12 T-cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis. J Gen Virol 71(Pt 2):333–341 · DOI · Paper page
  29. Gotuzzo E, Cabrera J, Deza L, Verdonck K, et al (2004) Clinical characteristics of patients in Peru with human T-cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin Infect Dis 39(7):939–944. Epub 2004 Sep 1 · DOI · Paper page
  30. Gout O, Baulac M, Gessain A, et al (1990) Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 322(6):383–388 · DOI · Paper page
  31. Hino S (2011) Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki. Proc Jpn Acad Ser B Phys Biol Sci 87(4):152–166 · DOI · Paper page
  32. Ibrahim F, de Thé G, Gessain A (1995) Isolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type 1. J Virol 69(11):6980–6993 · DOI · Paper page
  33. Inaba S, Okochi K, Sato H, et al (1999) Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection. Transfusion 39(10):1104–1110 · DOI
  34. Iwanaga M, Watanabe T, Utsunomiya A, et al (2010) Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 116(8):1211–1219. Epub 2010 May 6 · DOI · Paper page
  35. Izumo S (2010) Neuropathology of HTLV-1-associated myelopathy (HAM/TSP). Neuropathology (en attente d’impression) · DOI · Paper page
  36. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, et al (1982) A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218(4572):571–573 · DOI · Paper page
  37. Kaplan JE, Litchfield B, Rouault C, et al (1991) HTLVI-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient. Neurology 41(2(Pt 1)):192–197 · DOI
  38. Komurian F, Pelloquin F, de Thé G (1991) In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 65(7):3770–3778 · DOI · Paper page
  39. Koralnik IJ, Boeri E, Saxinger WC, et al (1994) Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission. J Virol 68(4):2693–2707 · DOI · Paper page
  40. Laperche S, Worms B, Pillonel J (2009) Blood safety strategies for human T-cell lymphotropic virus in Europe. Vox Sang 96(2):104–110 · DOI · Paper page
  41. Lee R, Schwartz RA (2011) Human T-lymphotrophic virus type 1-associated infective dermatitis: a comprehensive review. J Am Acad Dermatol 64(1):152–160. Epub 2010 Aug 5 · DOI
  42. Lee TH, Chafets DM, Busch MP, Murphy EL (2004) Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol 31(4):275–282 · DOI
  43. Liu HF, Goubau P, Van Brussel M, et al (1996) The three human T-lymphotropic virus type I subtypes arose from three geographically distinct simian reservoirs. J Gen Virol 77(Pt 2):359–368 · DOI
  44. Mahieux R, Chappey C, Georges-Courbot MC, et al (1998) Simian T-cell lymphotropic virus type 1 from Mandrillus sphinx as a simian counterpart of human T-cell lymphotropic virus type 1 subtype D. J Virol 72(12):10316–10322 · DOI · Paper page
  45. Mahieux R, Chappey C, Meertens L, et al (2000) Molecular characterization and phylogenetic analyses of a new simian T-cell lymphotropic virus type 1 in a wild-caught African baboon (Papio anubis) with an indeterminate STLV type 2-like serology. AIDS Res Hum Retroviruses 16(18):2043–2048 · DOI
  46. Mahieux R, Horal P, Mauclère P, et al (2000) Human T-cell lymphotropic virus type 1 gag indeterminate Western blot patterns in Central Africa: relationship to Plasmodium falciparum infection. J Clin Microbiol 38(11):4049–4057 · DOI
  47. Mahieux R, Ibrahim F, Mauclère P, et al (1997) Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies. J Virol 71(2):1317–1333 · DOI · Paper page
  48. Mahieux R, Pecon-Slattery J, Gessain A (1997) Molecular characterization and phylogenetic analyses of a new, highly divergent simian T-cell lymphotropic virus type 1 (STLV-1marc1) in Macaca arctoides. J Virol 71(8):6253–6258 · DOI · Paper page
  49. Malik KT, Even J, Karpas A (1988) Molecular cloning and complete nucleotide sequence of an adult T-cell leukaemia virus/human T-cell leukaemia virus type I (ATLV/HTLV-I) isolate of Caribbean origin: relationship to other members of the ATLV/HTLV-I subgroup. J Gen Virol 69(Pt 7):1695–1710 · DOI · Paper page
  50. Matsuoka M, Jeang KT (2011) Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 30(12):1379–1389. Epub 2010 Nov 29 · DOI · Paper page
  51. Matsuura E, Yamano Y, Jacobson S (2010) Neuroimmunity of HTLV-I infection. J Neuroimmune Pharmacol 5(3):310–325. Epub 2010 May 2 · DOI
  52. Mauclère P, Afonso P, Meertens L, et al (2011) HTLV-2B strains, similar to those found in several Amerindians tribes, are endemic in Centra African Bakola Pygmies. J Infect Dis 203(9):1316–1323 · DOI
  53. Mauclère P, Le Hesran JY, Mahieux R, et al (1997) Demographic, ethnic, and geographic differences between human T-cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa. J Infect Dis 176(2):505–509 · DOI
  54. Miura T, Fukunaga T, Igarashi T, et al (1994) Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background. Proc Natl Acad Sci USA 91(3): 1124–1127 · DOI · Paper page
  55. Miyoshi I, Yoshimoto S, Fujishita M, et al (1982) Natural adult T-cell leukemia virus infection in Japanese monkeys. Lancet 2(8299):658 · DOI
  56. Moens B, López G, Adaui V, et al (2009) Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination. J Clin Microbiol 47(11):3682–3691. Epub 2009 Sep 9 · DOI
  57. Montes M, Sanchez C, Verdonck K, et al (2009) Regulatory T-cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis 3(6):e456 · DOI · Paper page
  58. Nakamura T, Nishiura Y, Eguchi K (2009) Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Cent Nerv Syst Agents Med Chem 9(2):137–149 · DOI
  59. Oguma S, Imamura Y, Kusumoto Y, et al (1992) Accelerated declining tendency of human T-cell leukemia virus type I carrier rates among younger blood donors in Kumamoto, Japan. Cancer Res 52(9):2620–2623〈/other〉
  60. Olindo S, Cabre P, Lézin A, et al (2006) Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 63(11):1560–1566〈/other〉 · DOI · Paper page
  61. Olindo S, Lézin A, Cabre P, et al (2005) HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. J Neurol Sci 237(1–2): 53–59 · DOI
  62. Orland JR, Engstrom J, Fridey J, et al (2003) Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 61(11):1588–1594 · DOI · Paper page
  63. Ozden S, Cochet M, Mikol J, et al (2004) Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis. J Virol 78(19):10320–10327 · DOI
  64. Plancoulaine S, Buigues RP, Murphy EL, et al (1998) Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French Guiana. Int J Cancer 76(3):331–336 · doi:10.1002/(sici)1097-0215(19980504)76:3<331::aid-ijc8>3.0.co;2-w
  65. Poiesz BJ, Ruscetti FW, Gazdar AF, et al (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77(12):7415–7419 · DOI · Paper page
  66. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058–6068 · DOI · Paper page
  67. Roberts BD, Foung SK, Lipka JJ, et al (1993) Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II. J Clin Microbiol 31(2):260–264 · doi:10.1128/jcm.31.2.260-264.1993
  68. Roucoux DF, Murphy EL (2004) The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 6(3):144–154
  69. Roucoux DF, Wang B, Smith D, et al (2005) A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis 191(9):1490–1497. Epub 2005 Mar 31 · DOI · Paper page
  70. Rouet F, Rabier R, Foucher C, et al (1999) Geographical clustering of human T-cell lymphotropic virus type I in Guadeloupe, an endemic Caribbean area. Int J Cancer 81(3):330–334 · DOI
  71. Saito M (2010) Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1-(HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Interdiscip Perspect Infect Dis 2010:478461. Epub 2010 Feb 10 · DOI
  72. Salemi M, Van Dooren S, Audenaert E, et al (1998) Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains. Virology 246(2):277–287 · DOI
  73. Slattery JP, Franchini G, Gessain A (1999) Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res 9(6):525–540 · DOI · Paper page
  74. Sonoda S, Li HC, Cartier L, et al (2000) Ancient HTLV type 1 provirus DNA of Andean mummy. AIDS Res Hum Retroviruses 16(16):1753–1756 · DOI
  75. Stewart DM, Ramanathan R, Mahanty S, et al (2011) Disseminated Strongyloides stercoralis Infection in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma. Acta Haematol 126(6):63–67 · doi:10.1159/000324799
  76. Takahashi T, Takase H, Urano T, et al (2000) Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term followup. Ocul Immunol Inflamm 8(4):235–241 · doi:10.1076/ocii.8.4.235.6454
  77. Takatsuki K, Matsuoka M, Yamaguchi K (1996) Adult T-cell leukemia in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 13(Suppl 1):S15–S19 · DOI
  78. Thorstensson R, Albert J, Andersson S (2002) Strategies for diagnosis of HTLV-I and -II. Transfusion 42(6):780–791 · DOI
  79. Tsukasaki K, Hermine O, Bazarbachi A, et al (2009) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27(3):453–459. Epub 2008 Dec 8. · DOI · Paper page
  80. Tulius Silva M, de Melo Espíndola O, Bezerra Leite AC, Araújo A (2009) Neurological aspects of HIV/human T lymphotropic virus coinfection. AIDS Rev 11(2):71–78
  81. Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, et al (1999) Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer 82(6): 832–836 · DOI · Paper page
  82. Van Dooren S, Gotuzzo E, Salemi M, et al (1998) Evidence for a post-Columbian introduction of human T-cell lymphotropic virus (type I) (corrected) in Latin America. J Gen Virol 79(Pt 11): 2695–2708 · DOI · Paper page
  83. Varma M, Rudolph DL, Knuchel M, et al (1995) Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by Western blot (immunoblot) assay containing recombinant envelope glycoproteins. J Clin Microbiol 33(12):3239–3244 · doi:10.1128/jcm.33.12.3239-3244.1995
  84. Vine AM, Witkover AD, Lloyd AL, et al (2002) Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 186(7):932–939. Epub 2002 Sep 13 · DOI · Paper page
  85. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S (1995) Clonal expansion of Human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 69(5):2863–2868 · DOI · Paper page
  86. Wolfe ND, Heneine W, Carr JK, et al (2005) Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A 102(22):7994–7999. Epub 2005 May 23 · DOI · Paper page
  87. Yamaguchi K (1994) Human T-lymphotropic virus type I in Japan. Lancet 343(8891):213–216 · DOI · Paper page
  88. Yamaguchi K, Watanabe T (2002) Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol 76(Suppl 2):240–245 · DOI
  89. Yasunaga J, Matsuoka M (2007) Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms. Cancer Control 14(2):133–140 · DOI

Cited by

See all 58

Metadata

Authors
Gessain, A.
Venue
Bulletin de la Société de pathologie exotique
Publisher
Lavoisier
Published
2011-07-27
Volume
104
Issue
3
Pages
167-180
ISSN
  • 0037-9085 (ISSN-L)
  • 1961-9049
OpenAlex
W133530725
Cited by
58
References
5
FWCI
2.70
Type
journal article
Language
fr
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Le rétrovirus humain oncogène HTLV-1 : épidémiologie descriptive et moléculaire, origine, évolution et aspects diagnostiques et maladies associées. https://app.cochat.ai/papers/10.1007/s13149-011-0174-4
The paper
Gessain, A. (2011). Le rétrovirus humain oncogène HTLV-1 : épidémiologie descriptive et moléculaire, origine, évolution et aspects diagnostiques et maladies associées. Bulletin de la Société de pathologie exotique. https://doi.org/10.1007/s13149-011-0174-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.